SkyCell secures USD 116 million in Series D funding to expand global operations
scroll south
TOP 100 scale-up SkyCell has successfully closed a USD 116 million Series D funding round aiming to enhance its presence across the Americas, EMEA, and Asia, further solidifying its position in the global market.
Every month, SkyCell containers protect more than USD 2.5 billion of pharmaceutical goods, including millions of doses of vaccines, cancer treatments, diabetes care, and diagnostic solutions for patients around the world.To boost its pharma customers' Scope 3 decarbonization, SkyCell is expanding its fleet to offer more solutions that cut CO2 emissions beyond the 50% already achieved by its containers.
The Series D funding includes USD 59 million from Tybourne Capital Management and CC Industries, following a USD 57 million investment from Catalyst and M&G Investments.
SkyCell ranked among the TOP 100 Scale-ups in 2021 and 2022.
SkyCell Co-Founders Nico Ros and Richard Ettl
SkyCell AG: Pharma containers worldwide
SkyCell has become an award-winning provider of temperature-controlled container solutions with a special focus on emerging markets and sustainability and with one overriding goal: producing the safes... Read more
